Autoimmune diseases Clinical Trials: Active Studies by Market and Country

• 11markets with active trials
• 925active studies on Inflammatory Bowel Disease Treatment
• 31of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Inflammatory Bowel Disease Treatment925Inflammatory Bowel Disease Treatment: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Multiple Sclerosis Drugs784Multiple Sclerosis Drugs: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Rheumatoid Arthritis Drugs550Rheumatoid Arthritis Drugs: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Lupus Treatment537Lupus Treatment: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Psoriasis Treatment412Psoriasis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Myasthenia Gravis Treatment150Myasthenia Gravis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Axial Spondyloarthritis (axSpA)145Axial Spondyloarthritis (axSpA): See them on ClinicalTrials.gov (opens in a new tab)
8. 8IgA Nephropathy Treatment117IgA Nephropathy Treatment: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Vitiligo Treatment99Vitiligo Treatment: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Celiac Disease Treatment94Celiac Disease Treatment: See them on ClinicalTrials.gov (opens in a new tab)
11. 11JAK Inhibitors73JAK Inhibitors: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative Colitis

  NCT07932691Inflammatory Bowel Disease Treatment

• A Study of SL-325 in Crohn's Disease Patients

  NCT07753850Inflammatory Bowel Disease Treatment

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  NCT03816345Inflammatory Bowel Disease Treatment

• An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1

  NCT07932262Multiple Sclerosis Drugs

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019Multiple Sclerosis Drugs

• Pain Phenotyping of Rheumatic Diseases - An Observational Study

  NCT07829497Rheumatoid Arthritis Drugs

• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

  NCT06576271Lupus Treatment

• Deciphering the Genetic Architecture of Autoimmune Diseases

  NCT06948110Lupus Treatment

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483Psoriasis Treatment

• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  NCT04751396Psoriasis Treatment

• An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

  NCT06540144Myasthenia Gravis Treatment

• A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289Myasthenia Gravis Treatment

• A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521Myasthenia Gravis Treatment

• Effects of Resistance Exercise on Enthesitis in Patients With Spondyloarthritis

  NCT07923006Axial Spondyloarthritis (axSpA)

• A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight Subjects; and Pharmacokinetics at Different Subcutaneous Injection Sites at the Same Dose

  NCT07920861Axial Spondyloarthritis (axSpA)

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

  NCT07290036Axial Spondyloarthritis (axSpA)

• Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study

  NCT07931170IgA Nephropathy Treatment

• A Pharmacokinetic Study of Budesonide Delayed Release Tablet D23A (D23) in Healthy Chinese Participants Under Fasting Conditions

  NCT07925216IgA Nephropathy Treatment

• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  NCT07498335IgA Nephropathy Treatment

• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183Vitiligo Treatment

• Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

  NCT07437560Vitiligo Treatment

• VItiligo RegisTry adUlts And chiLdren-France

  NCT07927699Vitiligo Treatment

• EUS-CPN With and Without Bupivacaine

  NCT04951804Celiac Disease Treatment

• VTP-1000 in Adults With Celiac Disease

  NCT06310291Celiac Disease Treatment

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Biologics and biosimilars
• Bones and joints
• Gut health
• Brain and nerves
• Skin and hair